Prestige Consumer Healthcare financials
$46.74−0.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '27 Jun 30 | Q4 '26 Mar 31 | Q3 '26 Dec 31 | Q2 '26 Sep 30 | Q1 '26 Jun 30 | Q4 '25 Mar 31 | Q3 '25 Dec 31 | Q2 '25 Sep 30 | Q1 '25 Jun 30 | Q4 '24 Mar 31 | Q3 '24 Dec 31 | Q2 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $265.7M | $281.6M | $283.4M | $274.1M | $249.5M | $296.5M | $290.3M | $283.8M | $267.1M | $277.0M | $282.7M | $286.3M |
| Gross profit | $136.2M | $146.3M | $157.4M | $151.6M | $140.3M | $170.0M | $161.0M | $157.4M | $146.0M | $151.8M | $157.9M | $160.0M |
| Gross margin | 51.3% | 51.9% | 55.5% | 55.3% | 56.2% | 57.3% | 55.5% | 55.5% | 54.7% | 54.8% | 55.9% | 55.9% |
| Operating income | $52.5M | $75.5M | $82.5M | $79.7M | $71.8M | $88.4M | $92.0M | $84.3M | $72.0M | $82.2M | $86.8M | $88.3M |
| Net income | $29.2M | $53.9M | $46.7M | $42.2M | $47.5M | $50.1M | $61.0M | $54.4M | $49.1M | $49.5M | $53.0M | $53.6M |
| Net margin | 11.0% | 19.1% | 16.5% | 15.4% | 19.0% | 16.9% | 21.0% | 19.2% | 18.4% | 17.9% | 18.8% | 18.7% |
| Diluted EPS | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 |
| EBITDA | $61.3M | $83.8M | $90.1M | $87.3M | $79.4M | $108.1M | $98.8M | $92.3M | $80.2M | $82.2M | $94.5M | $95.9M |
| Operating cash flow | $70.8M | $42.8M | $78.3M | $57.5M | $79.0M | $61.8M | $65.1M | $69.8M | $54.8M | $66.9M | $71.5M | $62.5M |
| Free cash flow | $67.1M | $37.6M | $75.3M | $55.4M | $78.2M | $58.4M | $63.5M | $67.8M | $53.6M | $63.8M | $69.5M | $59.5M |
| Diluted shares | 47.6M | 47.7M | 48.1M | 49.3M | 49.8M | 50.1M | 50.0M | 50.0M | 50.3M | 50.3M | 50.1M | 50.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.1M | $63.9M | $62.4M | $119.1M | $139.5M | $97.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.04B | $1.01B | $1.05B | $1.02B | $1.02B | $1.02B |
| Total assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B |
| Total liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B |
| Shareholders' equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology